Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 291

1.

MObility ImproVEment with spasticity in multiple sclerosis in Europe: the MOVE 1 EU study.

Vermersch P.

Neurodegener Dis Manag. 2014 Dec;4(6):407-15. doi: 10.2217/nmt.14.44.

PMID:
25531685
[PubMed - in process]
2.

Adult-onset genetic leukoencephalopathies: A MRI pattern-based approach in a comprehensive study of 154 patients.

Ayrignac X, Carra-Dalliere C, Menjot de Champfleur N, Denier C, Aubourg P, Bellesme C, Castelnovo G, Pelletier J, Audoin B, Kaphan E, de Seze J, Collongues N, Blanc F, Chanson J, Magnin E, Berger E, Vukusic S, Durand-Dubief F, Camdessanche J, Cohen M, Lebrun-Frenay C, Brassat D, Clanet M, Vermersch P, Zephir H, Outteryck O, Wiertlewski S, Laplaud D, Ouallet J, Brochet B, Goizet C, Debouverie M, Pittion S, Edan G, Deburghgraeve V, Le Page E, Verny C, Amati-Bonneau P, Bonneau D, Hannequin D, Guyant-Maréchal L, Derache N, Louis Defer G, Moreau T, Giroud M, Guennoc AM, Clavelou P, Taithe F, Mathis S, Neau J, Magy L, Devoize JL, Bataillard M, Masliah-Planchon J, Dorboz I, Tournier-Lasserve E, Levade T, Boespflug Tanguy O, Labauge P.

Brain. 2014 Dec 19. pii: awu353. [Epub ahead of print]

PMID:
25527826
[PubMed - as supplied by publisher]
3.

High-affinity sigma-1 protein agonist reduces clinical and pathological signs of experimental auto-immune encephalomyelitis.

Oxombre B, Lee-Chang C, Duhamel A, Toussaint M, Giroux M, Donnier-Maréchal M, Carato P, Lefranc D, Zéphir H, Prin L, Melnyk P, Vermersch P.

Br J Pharmacol. 2014 Dec 17. doi: 10.1111/bph.13037. [Epub ahead of print]

PMID:
25521311
[PubMed - as supplied by publisher]
4.

[The influence of age and illness duration on cognitive impairment in aging patients with relapsing-remitting multiple sclerosis (RR-MS)].

Leclercq E, Cabaret M, Guilbert A, Jougleux C, Vermersch P, Moroni C.

Geriatr Psychol Neuropsychiatr Vieil. 2014 Sep;12(3):331-8. doi: 10.1684/pnv.2014.0482. French.

PMID:
25245320
[PubMed - in process]
5.

Comparison of 3D double inversion recovery and 2D STIR FLAIR MR sequences for the imaging of optic neuritis: pilot study.

Hodel J, Outteryck O, Bocher AL, Zéphir H, Lambert O, Benadjaoud MA, Chechin D, Pruvo JP, Vermersch P, Leclerc X.

Eur Radiol. 2014 Dec;24(12):3069-75. doi: 10.1007/s00330-014-3342-3. Epub 2014 Aug 23.

PMID:
25149294
[PubMed - in process]
6.

[Autologous stem cell transplantation for autoimmune diseases: recommendations from the SFGM-TC].

Farge D, Terriou L, Badoglio M, Cras A, Desreumaux P, Hadj-Khelifa S, Marjanovic Z, Moisan A, Dulery R, Faucher C, Hij A, Martin T, Vermersch P, Yakoub-Agha I.

Pathol Biol (Paris). 2014 Aug;62(4):204-8. doi: 10.1016/j.patbio.2014.05.012. Epub 2014 Jul 10. French.

PMID:
25017794
[PubMed - in process]
7.

Quality control for retinal OCT in multiple sclerosis: validation of the OSCAR-IB criteria.

Schippling S, Balk L, Costello F, Albrecht P, Balcer L, Calabresi P, Frederiksen J, Frohman E, Green A, Klistorner A, Outteryck O, Paul F, Plant G, Traber G, Vermersch P, Villoslada P, Wolf S, Petzold A.

Mult Scler. 2014 Jun 16. pii: 1352458514538110. [Epub ahead of print]

PMID:
24948688
[PubMed - as supplied by publisher]
8.

Social participation in patients with multiple sclerosis: correlations between disability and economic burden.

Kwiatkowski A, Marissal JP, Pouyfaucon M, Vermersch P, Hautecoeur P, Dervaux B.

BMC Neurol. 2014 May 27;14:115. doi: 10.1186/1471-2377-14-115.

PMID:
24884720
[PubMed - in process]
Free PMC Article
9.

[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects].

Lionnet C, Carra C, Ayrignac X, Levade T, Gayraud D, Castelnovo G, Besson G, Androdias G, Vukusic S, Confavreux C, Zaenker C, De Seze J, Collongues N, Blanc F, Tranchant C, Wallon D, Hannequin D, Gerdelat-Mas A, Brassat D, Clanet M, Zephir H, Outteryck O, Vermersch P, Labauge P.

Rev Neurol (Paris). 2014 Jun-Jul;170(6-7):445-53. doi: 10.1016/j.neurol.2014.01.675. Epub 2014 Apr 16. French.

PMID:
24746394
[PubMed - in process]
10.

Does fatigue complaint reflect memory impairment in multiple sclerosis?

Jougleux-Vie C, Duhin E, Deken V, Outteryck O, Vermersch P, Zéphir H.

Mult Scler Int. 2014;2014:692468. doi: 10.1155/2014/692468. Epub 2014 Mar 2.

PMID:
24724029
[PubMed]
Free PMC Article
11.

Radiologically isolated syndrome: 5-year risk for an initial clinical event.

Okuda DT, Siva A, Kantarci O, Inglese M, Katz I, Tutuncu M, Keegan BM, Donlon S, Hua le H, Vidal-Jordana A, Montalban X, Rovira A, Tintoré M, Amato MP, Brochet B, de Seze J, Brassat D, Vermersch P, De Stefano N, Sormani MP, Pelletier D, Lebrun C; Radiologically Isolated Syndrome Consortium (RISC); Club Francophone de la Sclérose en Plaques (CFSEP).

PLoS One. 2014 Mar 5;9(3):e90509. doi: 10.1371/journal.pone.0090509. eCollection 2014.

PMID:
24598783
[PubMed - in process]
Free PMC Article
12.

Effect of oral cladribine on time to conversion to clinically definite multiple sclerosis in patients with a first demyelinating event (ORACLE MS): a phase 3 randomised trial.

Leist TP, Comi G, Cree BA, Coyle PK, Freedman MS, Hartung HP, Vermersch P, Casset-Semanaz F, Scaramozza M; oral cladribine for early MS (ORACLE MS) Study Group.

Lancet Neurol. 2014 Mar;13(3):257-67. doi: 10.1016/S1474-4422(14)70005-5. Epub 2014 Feb 4.

PMID:
24502830
[PubMed - indexed for MEDLINE]
13.

Extensive myelitis associated with anti-NMDA receptor antibodies.

Outteryck O, Baille G, Hodel J, Giroux M, Lacour A, Honnorat J, Zéphir H, Vermersch P.

BMC Neurol. 2013 Dec 27;13:211. doi: 10.1186/1471-2377-13-211.

PMID:
24373538
[PubMed - indexed for MEDLINE]
Free PMC Article
14.

Milder multiple sclerosis course in patients with concomitant inflammatory bowel disease.

Zéphir H, Gower-Rousseau C, Salleron J, Simon O, Debouverie M, Le Page E, Bouhnik Y, Lebrun-Frenay C, Papeix C, Vigneron B, Allez M, Prin L, Cosnes J, Vermersch P, Colombel JF; for the CFSEP, GETAID and EPIMAD Groups.

Mult Scler. 2013 Dec 10;20(8):1135-1139. [Epub ahead of print]

PMID:
24326672
[PubMed - as supplied by publisher]
15.

Accuracy of postcontrast 3D turbo spin-echo MR sequence for the detection of enhanced inflammatory lesions in patients with multiple sclerosis.

Hodel J, Outteryck O, Ryo E, Bocher AL, Lambert O, Chéchin D, Zéphir H, Lacour A, Pruvo JP, Vermersch P, Leclerc X.

AJNR Am J Neuroradiol. 2014 Mar;35(3):519-23. doi: 10.3174/ajnr.A3795. Epub 2013 Nov 7.

PMID:
24200899
[PubMed - indexed for MEDLINE]
16.

[Cavitary lesions in multiple sclerosis: multicenter study on twenty patients].

Corlobé A, Renard D, Goizet C, Berger E, Rumbach L, Robinson A, Dupuy D, Touzé E, Zéphir H, Vermersch P, Brochet B, Edan G, Deburghgraeve V, Créange A, Castelnovo G, Cohen M, Lebrun-Frenay C, Boespflug-Tanguy O, Labauge P.

Rev Neurol (Paris). 2013 Dec;169(12):965-9. doi: 10.1016/j.neurol.2013.02.010. Epub 2013 Oct 17. French.

PMID:
24139243
[PubMed - in process]
17.

Teriflunomide versus subcutaneous interferon beta-1a in patients with relapsing multiple sclerosis: a randomised, controlled phase 3 trial.

Vermersch P, Czlonkowska A, Grimaldi LM, Confavreux C, Comi G, Kappos L, Olsson TP, Benamor M, Bauer D, Truffinet P, Church M, Miller AE, Wolinsky JS, Freedman MS, O'Connor P; TENERE Trial Group.

Mult Scler. 2014 May;20(6):705-16. doi: 10.1177/1352458513507821. Epub 2013 Oct 14.

PMID:
24126064
[PubMed - in process]
18.

JC-virus seroconversion in multiple sclerosis patients receiving natalizumab.

Outteryck O, Zéphir H, Salleron J, Ongagna JC, Etxeberria A, Collongues N, Lacour A, Fleury MC, Blanc F, Giroux M, de Seze J, Vermersch P.

Mult Scler. 2013 Sep 26. [Epub ahead of print]

PMID:
24072722
[PubMed - as supplied by publisher]
19.

L-selectin is a possible biomarker for individual PML risk in natalizumab-treated MS patients.

Schwab N, Schneider-Hohendorf T, Posevitz V, Breuer J, Göbel K, Windhagen S, Brochet B, Vermersch P, Lebrun-Frenay C, Posevitz-Fejfár A, Capra R, Imberti L, Straeten V, Haas J, Wildemann B, Havla J, Kümpfel T, Meinl I, Niessen K, Goelz S, Kleinschnitz C, Warnke C, Buck D, Gold R, Kieseier BC, Meuth SG, Foley J, Chan A, Brassat D, Wiendl H.

Neurology. 2013 Sep 3;81(10):865-71. doi: 10.1212/WNL.0b013e3182a351fb. Epub 2013 Aug 7.

PMID:
23925765
[PubMed - indexed for MEDLINE]
20.

Mixed connective tissue disease presenting as trigeminal neuropathy.

Hamoir B, Giroux M, Outteryck O, Launay D, Vermersch P.

Acta Neurol Belg. 2014 Sep;114(3):245-6. doi: 10.1007/s13760-013-0226-2. Epub 2013 Aug 1. No abstract available.

PMID:
23903962
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk